Literature DB >> 29501948

Salivary cortisol and alpha-amylase diurnal profiles and stress reactivity in children with Attention Deficit Hyperactivity Disorder.

Eleni Angeli1, Terpsichori Korpa2, Elizabeth O Johnson3, Filia Apostolakou4, Ioannis Papassotiriou4, George P Chrousos5, Panagiota Pervanidou5.   

Abstract

There is growing evidence for dysregulation of the stress system in individuals with Attention Deficit Hyperactivity Disorder (ADHD). The stress system includes neuroanatomical and functional components that function in concert to maintain homeostasis and its main effectors are the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic/adrenomedullary nervous system (SNS). As stress system activity demonstrates a distinct circadian variation, we aimed to describe simultaneously, diurnal rhythms of both the HPA axis and the SNS in children with ADHD and a comparison group. Moreover, we attempted to investigate stress responses to a physical stressor, venipuncture, in both groups. Sixty-two prepubertal children with ADHD combined (ADHD-C) or inattentive (ADHD-I) type and 40 typically developing children provided saliva samples at six specific time points during a day, as well as before and 10 min after a scheduled morning venipuncture. Salivary cortisol and α- amylase were selected as reliable noninvasive biomarkers for HPA axis and SNS function and were measured in the samples obtained. Results revealed that children with ADHD-C had lower mean cortisol values both 30 min after awakening and at 18:00 h than controls (p = 0.002 and p = 0.018 respectively), as well as lower mean Cortisol Awakening Response (CAR) and Area Under the Curve for "wake to bed" period (AUCi) values of cortisol (p = 0.004 and p = 0.001, respectively). Also, mean CAR and cortisol AUCi were lower in children with ADHD-I than the control group (p = 0.034 and p = 0.038 respectively). Alpha-amylase measurements showed an increase over time (p < 0.001), which was similar in all three groups. Interestingly, α-amylase changes over time were correlated with the corresponding cortisol changes (p < 0.001). Venipuncture, elicited a significant increase only in α-amylase levels and more so in the control group (p = 0.003). These findings suggest a partial hypofunction of the stress system in children with ADHD.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADHD; Cortisol; Diurnal rhythms; Stress response; Stress system; α-amylase

Mesh:

Substances:

Year:  2018        PMID: 29501948     DOI: 10.1016/j.psyneuen.2018.02.026

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  12 in total

1.  Exposure to antibiotics in the first 24 months of life and neurocognitive outcomes at 11 years of age.

Authors:  R F Slykerman; C Coomarasamy; K Wickens; J M D Thompson; T V Stanley; C Barthow; J Kang; J Crane; E A Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2019-04-30       Impact factor: 4.530

2.  The role of glucocorticoid receptor gene in the association between attention deficit-hyperactivity disorder and smaller brain structures.

Authors:  Claiton H D Bau; Diego L Rovaris; Cibele E Bandeira; Eugenio H Grevet; Renata B Cupertino; Maria E de Araujo Tavares; Clara S Gusmão; Djenifer B Kappel; Eduardo S Vitola; Felipe A Picon; Luís A Rohde; Bruna S da Silva
Journal:  J Neural Transm (Vienna)       Date:  2021-10-05       Impact factor: 3.575

Review 3.  Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System.

Authors:  Nor Amira Syahira Mohd Azmi; Norsham Juliana; Sahar Azmani; Nadia Mohd Effendy; Izuddin Fahmy Abu; Nur Islami Mohd Fahmi Teng; Srijit Das
Journal:  Int J Environ Res Public Health       Date:  2021-01-14       Impact factor: 3.390

4.  Stress/Immune Biomarkers in Saliva among Children with ADHD Status.

Authors:  Anna Krahel; Elzbieta Paszynska; Agnieszka Slopien; Maria Gawriolek; Justyna Otulakowska-Skrzynska; Szymon Rzatowski; Amadeusz Hernik; Tomasz Hanć; Ewa Bryl; Paula Szczesniewska; Karolina Bilska; Joanna Duda; Marta Tyszkiewicz-Nwafor; Monika Dmitrzak-Weglarz
Journal:  Int J Environ Res Public Health       Date:  2021-01-18       Impact factor: 3.390

5.  Childhood Trajectories of Hyperactivity/Inattention Symptoms and Diurnal Cortisol in Middle Adolescence: Results from a UK Birth Cohort.

Authors:  Dongying Ji; Eirini Flouri; Efstathios Papachristou; Marta Francesconi
Journal:  J Atten Disord       Date:  2021-08-11       Impact factor: 3.256

6.  Editorial: Stress and Neurodevelopment.

Authors:  Panagiota Pervanidou; Agorastos Agorastos; George P Chrousos
Journal:  Front Neurosci       Date:  2022-04-13       Impact factor: 4.677

7.  Effects of Green Color Exposure on Stress, Anxiety, and Pain during Peripheral Intravenous Cannulation in Dental Patients Requiring Sedation.

Authors:  Yukihiko Takemura; Kanta Kido; Hiromasa Kawana; Tatsuo Yamamoto; Takuro Sanuki; Yoshiharu Mukai
Journal:  Int J Environ Res Public Health       Date:  2021-06-01       Impact factor: 3.390

8.  Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction: A Nationwide Population-Based Study in Taiwan.

Authors:  Pin-Han Peng; Meng-Yun Tsai; Sheng-Yu Lee; Po-Cheng Liao; Yu-Chiau Shyu; Liang-Jen Wang
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390

9.  Saliva cortisol, melatonin levels and circadian rhythm alterations in Chinese primary school children with dyslexia.

Authors:  Yanhong Huang; Chongtao Xu; Meirong He; Wenlong Huang; Kusheng Wu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

10.  Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations.

Authors:  George P Chrousos; Petros P Sfikakis; Maria P Yavropoulou; Maria G Filippa; Aimilia Mantzou; Fotinie Ntziora; Maria Mylona; Maria G Tektonidou; Nikolaos I Vlachogiannis; Dimitrios Paraskevis; Gregory A Kaltsas
Journal:  Endocrine       Date:  2022-01-18       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.